Picture of RLS Global AB logo

RLS RLS Global AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: RLS Global Presents Positive Results From The ChloraSolv01 Study

Oct 13 (Reuters) - RLS Global AB  RLSC.ST :
    * RLS GLOBAL PRESENTS POSITIVE RESULTS FROM THE CHLORASOLV01
STUDY
AT THE LEADING EUROPEAN WOUND MANAGEMENT CONFERENCE, EWMA 2020
    * STUDY SHOWED LOW PAIN SCORE IN GENERAL.
    * MOST OF INVESTIGATORS/NURSES FOUND THAT DEBRIDEMENT WAS
EASIER
PERFORMED WITH CHLORASOLV THAN TREATMENTS PREVIOUSLY USED
    * OVERALL EVALUATION SHOWED 68,9% OF RESPONDERS AGREE
CHLORASOLV
DEBRIDEMENT GEL MAKES DEBRIDEMENT EASIER THAN PREVIOUSLY USED
DEBRIDING TREATMENTS, WHEREAS ONLY 3,8% DO NOT AGREE
    * THIS INVESTIGATION SHOWED THAT DEBRIDEMENT IN CONJUNCTION
WITH
USE OF CHLORASOLV WAS WELL TOLERATED AND EFFICIENT

Source text for Eikon:  ID:nWkr2PLkHN 
Further company coverage:  RLSC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on RLS Global AB

See all news